Mouse leukemia, L1210, strongly enhances its immunogenicity following in vivo treatment with 5-(3-3′-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC). Previous experiments have shown that transformed cells elicit a cell-mediated response accountable for rejection and resistance to a subsequent injection of parental tumor into a syngeneic host. L1210 expresses classical H-2 class I molecules, and since it has been shown that DTIC treatment does not modify the expression of these molecules, this is a suitable model to study nonclassical class I antigens, such as Qa2 glycoproteins, and their potential role in tumoregenicity.
Methods
Cloned cells from L1210 were treated with DTIC and then H-2D, and Qa antigen expression was studied on four clones, before and after xenogenization with DTIC.
Results and conclusions
a strong decrease of Qa2 molecule expression was demonstrated by radioimmunoassay and immunofluorescent staining and was confirmed by FACS and 2D-gel analysis. The presence or the absence of Qa antigens on tumor cells could thus be involved in tolerance or rejection of tumor cells in syngeneic animals.
AldrichC.J., LowenL.C., MannD., NishimuraM., HoudL., StroynowskiI., FormanI.: The Q7α3 domain alters T cell recognition of class I antigens. J. Immunol., 143: 3082–3089, 1991.
2.
AldrichC.J., WaltrigR., HermelE., AttayaM., Fischer LindahlK., MonacoJ.J., FormanJ.: T recognition of Qa-1b antigens on cells lacking a functional Tap-2. J. Immunol., 149: 3773–3777, 1992.
3.
BonmassarE., BonmassarA., VadlamudiS., GoldinA.: Antigenic changes of L1210 leukemia in mice treated with DTIC. Cancer Res., 32: 1446–1452, 1972.
4.
CantiG., RicciL., MarelliO., FrancoP., NicolinA.: Adoptive immunity in mice challenged with L1210/DTIC clones. Cancer Immunol. Immunother., 24: 64–70, 1987.
5.
DunhamL.J., StewartH.L.: A survey of transplantable and transmissible animal tumors. J. Natl. Cancer Inst., 13: 1299–1307, 1953.
6.
EyP.L., ProwseS.J., JenskinC.R.: Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum protein using protein A-sepharose. Immunochemistry, 15: 429–436, 1978.
7.
FernandezN., LabetaM., FestensteinH.: A novel class II molecule. Immunogenetics, 27: 363–370, 1988.
8.
FlahertyL.: In: Role of the Major Histocompatibility Complex in Immunology.DorfM. (Ed.), p. 35, Garland, New York, 1981.
9.
ImaniF., SoloskiM.: Heat shock protein can regulate expression of the Tla region encoded class Ib Qa-1. Proc. Natl. Acad. Sci. USA, 88: 10475–10481, 1991.
10.
JardetskyT.S., LaneW.S., RobinsonR.T., MaddenD.R., WileyD.C.: Identification of self peptides bound to purified HLA-B27. Nature, 353: 326–331, 1991.
11.
JenkinsM.K., AshwellJ.D., SchwartzR.H.: Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol., 140: 3324–3332, 1988.
12.
LaemmliU.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680–688, 1970.
13.
Le BouteillerP.P., MishalZ., LemonnierF.A., KourilskyF.M.: Quantification by flow cytofluorometry of HLA class I molecules at the surface of murine cells transformed by HLA genes. J. Immunol. Meth., 61: 30–38, 1983.
14.
MarelliO., FrancoP., CantiG., PrandoniN., RicciL.: Induction of new antigenic properties on DTIC-treated L1210 clones. Tumori, 74: 387–394, 1988.
15.
MarelliO., FrancoP., CantiG., RicciL., NicoliniA., FestensteinH.: DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity. Br. J. Cancer, 58: 171–180, 1988.
16.
MarelliO.E.A., FrancoP., LabetaM.O., FestensteinH.: Functional studies of H-2K-like epitopes on DTIC treated and untreated L1210 (H-2d) clones. J. Immunogenet., 16: 373–380, 1989.
17.
MellorA.L., AntonionJ., RobinsonP.: Structure and expression of genes encoding murine Qa-2 class I antigens. Proc. Natl. Acad. Sci. USA, 82: 5920–5928, 1985.
18.
NicolinA., CantiG., MarelliO., VeroneseF., GoldinA.: Chemotherapy of L1210 leukemic mice with antigenic tumor sublines. Cancer Res., 41: 1358–1366, 1981.
19.
NicoliniA., FrancoP., TestorelliC., GoldinA.: Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells. Cancer Res., 36: 222–229, 1976.
20.
NicolinA., VadlamudiS., GoldinA.: Antigenicity of L1210 leukemic sublines induced by drugs. Cancer Res., 32: 653–660, 1972.
21.
NicolinA., VeroneseF., MarelliO., GoldinA.: Immunological resistance to L1210 leukemia induced by L1210/DTIC cells. Cancer Immunol. Immunother., 9: 43–50, 1980.
22.
O'FarrellP.Z., GodmanH.M., O'FarrellG.: High resolution two dimensional electrophoresis of basic as well as acidic protein. Cell, 12: 1133–1140, 1977.
23.
OzatoK., MayerM., SachsD.: Monoclonal antibodies to mouse major histocompatibility complex antigens. IV. A series of hybridoma clones producing anti H-2d antibodies and an examination of expression of H-2d antigens on the surface of these cells. Transplantation, 34: 113–121, 1982.
24.
Reyes-EngelA., LeroyE., DiegnesJ.L., FernandezN.: Unusual expression pattern of the MHC class IQ5k gene in the AKR mouse: possible role in embryo development. J. Reprod. Immunol., 23: 73–80, 1993.
25.
SolanaR., FernandezM.C., AlonsoC., NavarreteC., SachsJ.A., FestensteinH.: Comparison of RIA and ELISA for screening class II monoclonal antibodies with EBV transformed B cell lines. Dis. Markers, 2: 23–30, 1984.
26.
TownsendA., BodmerH.: Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol., 7: 601–609, 1989.
27.
VidovicD., RogichM., McKuneK., GuerderS., McKayC., DembicZ.: Qa-1 restricted recognition of foreign antigen by a Γδ T cell hybridoma. Nature, 340: 646–651, 1989.
28.
WarnerC.M., GollnickS.O., FlahertyL., GoldbardS.B.: Analysis of Qa-2 antigen expression by preimplantation mouse embryos: possible relationship to the preimplantation embryo development. Biol. Reprod., 36: 611–618, 1987.
29.
WarnerC.M., GollnickS.O., GoldbardS.B.: Linkage of the preimplantation embryo development gene to the mouse major histocompatibility complex. Biol. Reprod., 36: 606–615, 1987.
30.
WattsB., DavisA.C., GantB., WheelerC., HillL., GoodenowR.S.: Organization and structure of the Qa genes of the major histocompatibility complex of the C3H mouse. Implication for Qa function and class I evolution. Embo J., 8: 1749–1757, 1989.
